Hangzhou, China · Founded 2016 · Privately Held (backing)
Developer of biotechnology therapies specializing in autoimmune diseases, immuno-oncology, and metabolic disorders. TJ Biopharma is based in Hangzhou, China and was founded in 2016. Its last reported valuation was $459 million in Sep 2025. It has raised $84.2 million.
Last reported valuation
$459.2M
Oct 2026
Priced at
—
Total raised
$84.2M
Last round
—
Team — not yet on record
No current team members for TJ Biopharma are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of TJ Biopharma with a free account
·The complete investor list: 13 names
·Watch TJ Biopharma: the Monday email on marks, rounds and moves
